Cargando…
Rare variants of the 3’-5’ DNA exonuclease TREX1 in early onset small vessel stroke
Background: Monoallelic and biallelic mutations in the exonuclease TREX1 cause monogenic small vessel diseases (SVD). Given recent evidence for genetic and pathophysiological overlap between monogenic and polygenic forms of SVD, evaluation of TREX1 in small vessel stroke is warranted. Methods: We se...
Autores principales: | McGlasson, Sarah, Rannikmäe, Kristiina, Bevan, Steven, Logan, Clare, Bicknell, Louise S., Jury, Alexa, Jackson, Andrew P., Markus, Hugh S., Sudlow, Cathie, Hunt, David P.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717473/ https://www.ncbi.nlm.nih.gov/pubmed/29387804 http://dx.doi.org/10.12688/wellcomeopenres.12631.1 |
Ejemplares similares
-
Biochemical and cellular characteristics of the 3′ → 5′ exonuclease TREX2
por: Chen, Ming-Jiu, et al.
Publicado: (2007) -
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
por: Vanpouille-Box, Claire, et al.
Publicado: (2017) -
Benchmarking network-based gene prioritization methods for cerebral small vessel disease
por: Zhang, Huayu, et al.
Publicado: (2021) -
The cytosolic exonuclease TREX1 inhibits the innate immune response to HIV-1
por: Yan, Nan, et al.
Publicado: (2010) -
DNA binding induces active site conformational change in the human TREX2 3′-exonuclease
por: de Silva, Udesh, et al.
Publicado: (2009)